| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |